Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
Anakinra versus placebo for acute myocarditis
2016-003433-20Phase 2Completed
- Sponsor
- Assistance publique - Hôpitaux de Paris
- Start
- Nov 2016
- Modality
- Cytokines & Interferons → Recombinant Proteins and Enzymes
- Countries
- 1
01
Overview
Phase 2, randomised, double-blind trial in acute myocarditis comparing Anakinra arm with Placebo arm (2 arms). Primary endpoint: Days alive and free of myocarditis complications within 28 days. Started Nov 2016; status: completed.
02
Drugs
anakinra
03
Conditions
acute myocarditis
Beyond the preview
Go deeper on 2016-003433-20.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on 2016-003433-20.